{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:52:07Z","timestamp":1765889527396,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Shrimp is a common but understudied food allergen with relatively high rates of emergency department visits. Here we report the shrimp OIT outcomes in the MOTIF (NCT03504774) clinical trial and discuss some of the challenges with performing this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this phase 2 clinical trial, 12 shrimp allergic participants aged 7\u201355 years (median age 21.5 years) were enrolled to receive shrimp OIT. Shrimp OIT was performed up to a maintenance dose of 1,000\u2005mg shrimp protein by week 28 with desensitization to shrimp assessed by double-blind placebo-controlled food challenge at week 52 followed by switching to avoidance and assessing sustained unresponsiveness (SU) at week 58. The primary endpoint was the change in CD28 in CD4+ allergen specific (CD154+) T-cells at baseline and 52 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Shrimp OIT induced desensitization to a cumulative 4,043\u2005mg shrimp protein in 58.3% (7\/12) of the intention to treat and 87.5% (7\/8) of the per protocol group after 52 weeks of shrimp OIT. Most shrimp OIT participants who remained in the study after desensitization (87.5%, 7\/8) achieved SU. Although adverse events were common during shrimp OIT (75%), most were mild (Bock grade 1, 88%) and there were no severe (Bock grade 3+) reactions or use of epinephrine. No significant differences in CD28 expression were observed after shrimp OIT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Shrimp OIT is safe and effective for the treatment of shrimp allergy. Most participants were successful and achieved SU after 6 weeks of avoidance.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2025.1458131","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:29:54Z","timestamp":1753162194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF"],"prefix":"10.3389","volume":"6","author":[{"given":"Shirley Y.","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Raeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinara","family":"Bogetic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monali","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holden T.","family":"Maeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Feight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Woch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Sharon","family":"Chinthrajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayantani B.","family":"Sindher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1081-1206(10)62258-2","article-title":"The impact of childhood food allergy on quality of life","volume":"87","author":"Sicherer","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1081-1206(10)60908-8","article-title":"The impact of food allergy on the daily activities of children and their families","volume":"96","author":"Bollinger","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1398-9995.2008.01843.x","article-title":"Impact of peanut allergy on quality of life, stress and anxiety in the family","volume":"64","author":"King","year":"2009","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pedn.2006.05.007","article-title":"\u201cLiving with risk\u201d: mothering a child with food-induced anaphylaxis","volume":"22","author":"Gillespie","year":"2007","journal-title":"J Pediatr Nurs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1365-2222.2007.02758.x","article-title":"The psychosocial impact of anaphylaxis on young people and their parents","volume":"37","author":"Akeson","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1398-9995.2010.02342.x","article-title":"The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review","volume":"65","author":"Gillespie","year":"2010","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2500\/aap.2017.38.4028","article-title":"The emotional, social, and financial burden of food allergies on children and their families","volume":"38","author":"Patel","year":"2017","journal-title":"Allergy Asthma Proc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 Oral immunotherapy for peanut allergy","volume":"379","author":"Investigators","year":"2018","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jaip.2020.12.029","article-title":"Continuous and daily oral immunotherapy for peanut allergy: results from a 2-year open-label follow-on study","volume":"9","author":"Vickery","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/all.15027","article-title":"Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy","volume":"77","author":"Fernandez-Rivas","year":"2022","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.anai.2022.07.033","article-title":"Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials","volume":"129","author":"Ciaccio","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/pai.13517","article-title":"Oral immunotherapy in severe cow\u2019s milk allergic patients treated with omalizumab: real life survey from a Spanish registry","volume":"32","author":"Ibanez-Sandin","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1651-2227.2012.02815.x","article-title":"Milk oral immunotherapy is effective in school-aged children","volume":"102","author":"Salmivesi","year":"2013","journal-title":"Acta Paediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jaip.2022.10.039","article-title":"Successful baked egg and baked milk oral immunotherapy in a pediatric cohort","volume":"11","author":"Zhang","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e13679","DOI":"10.1111\/pai.13679","article-title":"Shrimp-allergic patients in a multi-food oral immunotherapy trial","volume":"33","author":"Nguyen","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e185630","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1542\/peds.2011-0204","article-title":"The prevalence, severity, and distribution of childhood food allergy in the United States","volume":"128","author":"Gupta","year":"2011","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.anai.2022.02.003","article-title":"Seafood-induced anaphylaxis in children presenting to Canadian emergency departments: rates, clinical presentation, and management","volume":"128","author":"Sehayek","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"E1286","DOI":"10.1073\/pnas.1520180113","article-title":"Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets","volume":"113","author":"Ryan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaci.2017.05.045","article-title":"Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired","volume":"141","author":"Pellerin","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy And Clinical Immunology PRACTALL consensus report","volume":"130","author":"Sampson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/0091-6749(88)90135-2","article-title":"Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual","volume":"82","author":"Bock","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S2468-1253(17)30392-8","article-title":"Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial","volume":"3","author":"Andorf","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eclinm.2018.12.006","article-title":"A phase 2 randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in multifood allergic individuals","volume":"7","author":"Andorf","year":"2019","journal-title":"EClinicalMedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.nut.2010.12.001","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report","volume":"27","author":"Boyce","year":"2011","journal-title":"Nutrition"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","article-title":"Food allergy: a practice parameter update-2014","volume":"134","author":"Sampson","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000048166","article-title":"Identification of continuous, allergenic regions of the major shrimp allergen pen a 1 (tropomyosin)","volume":"127","author":"Ayuso","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1046\/j.1365-2222.2003.01722.x","article-title":"Immunoglobulin E antibody reactivity to the major shrimp allergen, tropomyosin, in unexposed orthodox Jews","volume":"33","author":"Fernandes","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jaip.2018.04.035","article-title":"Oral allergy syndrome in shrimp and house dust mite allergies","volume":"6","author":"Tuano","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000486855","article-title":"Misleading allergens in the diagnosis of latex allergy: profilin and cross-reactive carbohydrate determinants","volume":"176","author":"Gurlek","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1389203723666220815095725","article-title":"Birch pollen allergens","volume":"23","author":"Li","year":"2022","journal-title":"Curr Protein Pept Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/all.15217","article-title":"Phase 2, randomized multi oral immunotherapy with omalizumab \u201creal life\u201d study","volume":"77","author":"Sindher","year":"2022","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.3390\/ijms25084531","article-title":"Variation in shrimp allergens: place of origin effects on food safety assessment","volume":"25","author":"Dorney","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1398-9995.2011.02663.x","article-title":"Tropomyosin IgE-positive results are a good predictor of shrimp allergy","volume":"66","author":"Gamez","year":"2011","journal-title":"Allergy"},{"key":"B38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/cea.12416","article-title":"Clinical and immunochemical profiles of food challenge proven or anaphylactic shrimp allergy in tropical Singapore","volume":"45","author":"Thalayasingam","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1365-2222.2008.02979.x","article-title":"Specific allergy to Penaeus monodon (seawater shrimp) or Macrobrachium rosenbergii (freshwater shrimp) in shrimp-allergic children","volume":"38","author":"Jirapongsananuruk","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1111\/all.15370","article-title":"Comprehending the allergen repertoire of shrimp for precision molecular diagnosis of shrimp allergy","volume":"77","author":"Wai","year":"2022","journal-title":"Allergy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaip.2020.08.057","article-title":"Cell-Based functional IgE assays are superior to conventional allergy tests for shrimp allergy diagnosis","volume":"9","author":"Wai","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"AB378","DOI":"10.1016\/j.jaci.2023.11.909","article-title":"Omalizumab for the treatment of multiple food allergy (OUtMATCH)","volume":"153","author":"Wood","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1458131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:29:56Z","timestamp":1753162196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1458131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":42,"alternative-id":["10.3389\/falgy.2025.1458131"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1458131","relation":{},"ISSN":["2673-6101"],"issn-type":[{"type":"electronic","value":"2673-6101"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"article-number":"1458131"}}